Making it in Manufacturing

Register your interest for 2027 here: https://www.cphi.com/europe/register-attend/?utm_source=partner&utm_medium=referral&utm_campaign=hln27cpw-cl-arto On the first day of CPHI Milan 2026, the Digital CMC Consortium launched: a pre-competitive, not-for-profit collaboration across the industry to digitise end-to-end CMC, founded with participation from companies including Novartis, Takeda a...

Register your interest for 2027 here: https://www.cphi.com/europe/register-attend/?utm_source=partner&utm_medium=referral&utm_campaign=hln27cpw-cl-arto Quotient Sciences has announced interim results from its AI-driven clinical trial. After three years developing AI for formulation development, with 30 to 50% time savings, Quotient took the approach into the clinic to see if it could also...

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes. Register your interest for 2027 here: https://www.cphi.com/europe/register-attend/?utm_source=partner&utm_medium=referral&utm_campaign=hln27cpw-cl-arto A year ago, InstaPill was adding a new block to take its capacity in India to 50...

Drug discovery and clinical development have all benefited from the COVID era and the AI era, but for Sheena Dempsey, manufacturing is still stuck somewhat in the dark ages. As President and CEO of CAI, she wants to drive automation and acceleration that get medicines into the hands of patients faster. This week on Making It In Manufacturing, Elliot Payne sat down with Sheena Dempsey, President an...

This week on Making It In Manufacturing, we’re bringing you our CEO panel from CPHI Milan 2026. ARTO Co-Founder and CEO Elliot Payne sat down with three CDMO CEOs: Dr Hanns-Christian Mahler of ten23 health, Dr Adriana Kiędzierska-Mencfeld of Rezon Bio and Philippe Clavel of Curapath, to ask how they weigh capacity risk against indication risk. In this panel: - Why ordering a sterile filling machin...

53Biologics is adding new lyophilisation equipment and an isolator to its facilities, completing its fill and finish capabilities so the company is fully end to end. That means the small batches first clinical trials need can stay under one roof. On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Javier Santos, Business Developer at 53Biologics, about the company's new in-house lyophi...

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes. This week on Making It In Manufacturing, Thomas McMann sat down with Dr Amy Walker, CEO of 4basebio. In this episode, Amy covers: • Why DNA has been made the same way for 50 years, and what changes when you take the bacteria out of the proc...

Ensera has launched the Ensera Alliance Network at CPHI Milan 2026. It brings like-minded companies together across the value chain, from drug product manufacturing and fill finish to assembly, packaging and serialisation. On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Darren Hieber, VP Alliance Partnerships at Ensera, about the network and what it offers pharma companies. In this epi...

For Pep Gubau, AI is ready for pharma manufacturing, and the results are already measurable: one of Aizon's early adopters, a plasma derivatives manufacturer, raised its yield by 4% in three months, worth $30 million. This year CPHI gave AI a dedicated zone of its own. On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Pep Gubau, CEO and Founder of Aizon, about where AI is delivering...

CinnaGen is the first company from its region to receive a European marketing authorisation for a biosimilar. Present in more than 40 countries, CinnaGen is now coming to Europe for the first time. On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Haleh Hamedifar, Chairperson of CinnaGen, about the approval and the partners CinnaGen is looking for in Europe. In this episode, Haleh covers...

Peptide manufacturing needs to grow to ten times today's output within five years, driven by GLP-1s and other peptide therapies. For Dr. Abdelaziz Toumi, meeting demand on that scale takes alliances built for the whole modality, not for one company. This week on Making It In Manufacturing, William Keutenius sat down with Dr. Abdelaziz Toumi, CEO of Lupin Manufacturing Solutions, Lupin's CD...

Onyx Scientific has announced a £1.5 million investment in its Sunderland facility to increase its GMP manufacturing capacity. More suites let Onyx ramp up commercial production while keeping the speed and flexibility its early phase clients need. On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Chris Atherton, Commercial Director at Onyx Scientific, about the investment and what it mea...

Before CPHI Milan 2026, Tom and Elliot put seven questions to each other about what CPHI means, how to make the most of it, and what ARTO is bringing to the show as its official podcast partner. Thomas McMann, host of Making It In Manufacturing, and Elliot Payne, co-founder of ARTO, answer them on a street corner, a rooftop, an arcade and the local pub, one question at a time. In this episode, Tom...

For three days every year, the global pharmaceutical industry comes together in one place. For Dr. Abdelaziz Toumi, that makes CPHI much more than a trade show: it is the industry's pulse check. This week on Making It In Manufacturing, Thomas McMann sat down with Dr. Abdelaziz Toumi, CEO of Lupin Manufacturing Solutions, ahead of CPHI Milan 2026. In this episode, Abdel covers: (00:37) Why CPHI...

Across pharma, companies face the same sustainability challenges, yet most are still trying to solve them alone. A new summit at CPHI Milan is designed to change that. This week on Making It In Manufacturing, Thomas McMann sat down with Silvia Forroova, Director of Partnerships and Sustainability at CPHI, with almost 20 years of experience in the events industry spanning strategic partnerships, su...

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes. This week on Making It In Manufacturing, Thomas McMann sat down with Tara Dougal, Event Director for CPHI Milan. In this episode, Tara covers: • Why CPHI Milan 2026 is built around doing a year's worth of business in three days, and wha...

What does it take to manage multi-billion dollar pharmaceutical projects while balancing technical complexity, stakeholder alignment, and constant change? In this episode, Hans Lindenberg Stentoft shares lessons from leading major capital projects at @Novo Nordisk, why CIP is often overlooked, and how preparation, communication, and early decision making can determine project success. This week on...

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes. This week on Making It In Manufacturing, Thomas McMann sat down with Chris Leman (UK Chair), Trina Ives (NE Chair), and Zam Thahir (EAC Chair), the UK leadership of ISPE UK , recorded at AstraZeneca's site in Macclesfield during the first ISPE UK Emerg...

This week on Making It In Manufacturing, Thomas McMann sat down with Thomas Emerik Rasmussen, a project and operations leader specialising in lean manufacturing and operational excellence, with over 15 years at Novo Nordisk spanning nine different roles across Denmark, Italy and the United States, building and leading large CapEx expansion projects before moving into consulting to help companies t...

95% of our viewers aren't subscribed. If you're watching and not yet subscribed, please subscribe to the channel so you don't miss future episodes. What does it actually take to deliver a pharmaceutical facility project without it going off the rails? This week, Thomas McMann sat down with someone who has spent over 30 years doing exactly that, from both sides of the table. This week on Making It...

What does it take to transform a biologics manufacturing business into a global CDMO leader while keeping culture, transparency and patient impact at the centre of every decision? This week on Making It In Manufacturing, Thomas McMann sat down with Lars Petersen, CEO of Fujifilm Biotechnologies, with more than 30 years of experience spanning biologics manufacturing, engineering, operations leaders...

95% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes. This week on Making It In Manufacturing, Thomas McMann sat down with Sarah Griffin, Event Manager for CPHI Americas. In this episode, Sarah covers: • Why CPHI Americas is creating a more focused, content-led experience built around meaningful industry...

95% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes. What does it take to build a CDMO designed around speed, integration, and true scientific collaboration? This week on Making It In Manufacturing, Harry Sloan sat down with LakshmiDevi Ethirajan, Co-Founder & CEO of SmaBioLabs, with 25+ years of exp...

95% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes. How do leading CDMOs move beyond manufacturing to become true development partners? In this episode, Jeffrey Speicher shares how integrated development, technical problem solving and long-term partnerships are shaping growth in outsourced pharma manufa...

95% of our viewers aren’t subscribed. If you’re watching and not yet subscribed, please subscribe to the channel so you don’t miss future episodes. The CDMO landscape is crowded, fragmented, and increasingly complex. What does it take to stand out and lead in such a competitive space? This week on Making It In Manufacturing, Harry Sloan sat down with Tom Sellig, CEO of Adare Pharma Solutions with...